ID

35264

Descrição

Study ID: 100449 Clinical Study ID: 100449 Study Title: Long-term Follow-Up studies at Years 16-20, to evaluate the persistence of immune response of GSK Biologicals’ hepatitis B vaccine in newborns of HBeAg+ and HBsAg+ mothers in comparison with a historical control group Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00240539 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis B Vaccine, Recombinant Trade Name: Engerix-B Study Indication: Hepatitis B

Palavras-chave

  1. 25/02/2019 25/02/2019 -
Titular dos direitos

GSK group of companies

Transferido a

25 de fevereiro de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Persistence of immune response of Hepatitis B vaccine in newborns of HBeAg+ and HBsAg+ mothers

Visit 22 - 26 (Follow-Up)

Visit 22 (Year 16) Follow-up
Descrição

Visit 22 (Year 16) Follow-up

Protocol
Descrição

Protocol

Tipo de dados

integer

Center
Descrição

Center

Tipo de dados

integer

Date of visit
Descrição

Date of visit

Tipo de dados

date

Subject Number
Descrição

Subject Number

Tipo de dados

integer

INFORMED CONSENT
Descrição

INFORMED CONSENT

I certify that Informed Consent has been obtained prior to any study procedure.
Descrição

I certify that Informed Consent has been obtained prior to any study procedure.

Tipo de dados

boolean

Informed Consent Date
Descrição

InformedConsentDate

Tipo de dados

date

DEMOGRAPHICS
Descrição

DEMOGRAPHICS

Date of birth:
Descrição

PREVIOUS STUDY: 103860/272 (EXT: HBV-115) Subject number will be the same as in the previous study.

Tipo de dados

date

Gender
Descrição

Gender

Tipo de dados

text

Race
Descrição

Race

Tipo de dados

text

If Other, please specify race
Descrição

OtherRace

Tipo de dados

text

Height
Descrição

Height

Tipo de dados

integer

Unidades de medida
  • cm
cm
Weight
Descrição

Weight

Tipo de dados

float

Unidades de medida
  • kg
kg
LABORATORY TESTS
Descrição

LABORATORY TESTS

Has a blood sample been taken?
Descrição

BLOOD SAMPLE

Tipo de dados

boolean

If Yes, please record the date
Descrição

DateBloodSampleTaken

Tipo de dados

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descrição

PreviousHepatitisVaccination

Tipo de dados

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descrição

PreviousHistoryOfHipatitisB

Tipo de dados

boolean

If Yes, please specify below
Descrição

Specify

Tipo de dados

text

Visit 23 (Year 17) Follow-up
Descrição

Visit 23 (Year 17) Follow-up

Date of visit
Descrição

VisitDate

Tipo de dados

date

LABORATORY TESTS
Descrição

LABORATORY TESTS

Has a blood sample been taken?
Descrição

BLOOD SAMPLE

Tipo de dados

boolean

Please specify the date of blood sample taken
Descrição

DateBloodSampleTaken

Tipo de dados

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descrição

PreviousHepatitisBVaccination

Tipo de dados

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descrição

PreviousHistoryOfHepatitisB

Tipo de dados

boolean

If Yes, please specify
Descrição

Specify

Tipo de dados

text

Visit 24 (Year 18) Follow-up
Descrição

Visit 24 (Year 18) Follow-up

Date of visit
Descrição

Visit Date

Tipo de dados

date

LABORATORY TESTS
Descrição

LABORATORY TESTS

Has a blood sample been taken?
Descrição

BLOOD SAMPLE

Tipo de dados

boolean

Please specify the date of blood sample taken
Descrição

DateBloodSampleTaken

Tipo de dados

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descrição

PreviousHepatitisBVaccination

Tipo de dados

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descrição

PreviousHistoryOfHepatitisB

Tipo de dados

boolean

If Yes, please specify
Descrição

Specify

Tipo de dados

text

Visit 25 (Year 19) Follow-up
Descrição

Visit 25 (Year 19) Follow-up

Date of visit
Descrição

VisitDate

Tipo de dados

date

LABORATORY TESTS
Descrição

LABORATORY TESTS

Has a blood sample been taken?
Descrição

BLOOD SAMPLE

Tipo de dados

boolean

Please specify the date of blood sample taken
Descrição

DateBloodSampleTaken

Tipo de dados

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descrição

PreviousHepatitisBVaccination

Tipo de dados

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descrição

PreviousHistoryOfHepatitisB

Tipo de dados

boolean

If Yes, please specify
Descrição

Specify

Tipo de dados

text

Visit 26 (Year 20) Follow-up
Descrição

Visit 26 (Year 20) Follow-up

Date of visit
Descrição

VisitDate

Tipo de dados

date

LABORATORY TESTS
Descrição

LABORATORY TESTS

Has a blood sample been taken?
Descrição

BLOOD SAMPLE

Tipo de dados

boolean

Please specify the date of blood sample taken
Descrição

DateBloodSampleTaken

Tipo de dados

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descrição

PreviousHepatitisBVaccination

Tipo de dados

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descrição

PreviousHistoryOfHepatitisB

Tipo de dados

boolean

If Yes, please specify
Descrição

Specify

Tipo de dados

text

FOLLOW-UP STUDIES
Descrição

FOLLOW-UP STUDIES

Would the subject be willing to participate in a follow-up study?
Descrição

FollowUpStudiesParticipation

Tipo de dados

boolean

If No, please specify
Descrição

If No, please specify

Tipo de dados

text

If AE or SAE, please specify
Descrição

AE/SAE

Tipo de dados

text

If Other, please specify
Descrição

OtherSpecify

Tipo de dados

text

INVESTIGATOR'S SIGNATURE
Descrição

INVESTIGATOR'S SIGNATURE

I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
Descrição

Investigator'sConfirmationDate

Tipo de dados

date

Investigator's signature
Descrição

Investigator's signature

Tipo de dados

text

Printed Investigator's name
Descrição

Printed Investigator's name

Tipo de dados

text

Reason for non participation
Descrição

Reason for non participation

Protocol number
Descrição

Protocol number

Tipo de dados

integer

Center
Descrição

Center

Tipo de dados

integer

Previous study
Descrição

e.g., 103860 / 272 (EXT:HBV-115)

Tipo de dados

text

Tracking Document
Descrição

Tracking Document

Previous Subject Number
Descrição

Previous Subject Number

Tipo de dados

integer

Date of Birth
Descrição

BirthDate

Tipo de dados

date

Please document reason for non participation
Descrição

Please document reason for non participation

Tipo de dados

text

In case of death, please specify date
Descrição

DeathDate

Tipo de dados

date

Date of Contact
Descrição

Date of Contact

Tipo de dados

date

Investigator's Signature
Descrição

Investigator's Signature

Investigator name
Descrição

please PRINT name

Tipo de dados

text

Signature:
Descrição

Signature:

Tipo de dados

text

Date:
Descrição

Date:

Tipo de dados

date

Similar models

Visit 22 - 26 (Follow-Up)

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Visit 22 (Year 16) Follow-up
Protocol
Item
Protocol
integer
Center
Item
Center
integer
Date of visit
Item
Date of visit
date
Subject Number
Item
Subject Number
integer
Item Group
INFORMED CONSENT
I certify that Informed Consent has been obtained prior to any study procedure.
Item
I certify that Informed Consent has been obtained prior to any study procedure.
boolean
InformedConsentDate
Item
Informed Consent Date
date
Item Group
DEMOGRAPHICS
Date of birth:
Item
Date of birth:
date
Item
Gender
text
Code List
Gender
CL Item
Male (1)
CL Item
Female (2)
Item
Race
text
Code List
Race
CL Item
Black (1)
CL Item
Arabic/North African (2)
CL Item
White/Caucasian (3)
CL Item
East & South East Asian (4)
CL Item
South Asian (5)
OtherRace
Item
If Other, please specify race
text
Height
Item
Height
integer
Weight
Item
Weight
float
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
If Yes, please record the date
date
PreviousHepatitisVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHipatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify below
text
Item Group
Visit 23 (Year 17) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 24 (Year 18) Follow-up
Visit Date
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 25 (Year 19) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 26 (Year 20) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
FOLLOW-UP STUDIES
FollowUpStudiesParticipation
Item
Would the subject be willing to participate in a follow-up study?
boolean
Item
If No, please specify
text
Code List
If No, please specify
CL Item
Adverse Events, or Serious Adverse Events (1)
CL Item
Other (2)
AE/SAE
Item
If AE or SAE, please specify
text
OtherSpecify
Item
If Other, please specify
text
Item Group
INVESTIGATOR'S SIGNATURE
Investigator'sConfirmationDate
Item
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
date
Investigator's signature
Item
Investigator's signature
text
Printed Investigator's name
Item
Printed Investigator's name
text
Item Group
Reason for non participation
Protocol number
Item
Protocol number
integer
Center
Item
Center
integer
Previous study
Item
Previous study
text
Item Group
Tracking Document
Previous Subject Number
Item
Previous Subject Number
integer
BirthDate
Item
Date of Birth
date
Item
Please document reason for non participation
text
Code List
Please document reason for non participation
CL Item
Subject not eligible (1)
CL Item
Subject lost to follow-up or not reached (2)
CL Item
Subject eligible but not willing to participate due to adverse events, or serious adverse event (3)
CL Item
Subject eligible but not willing to participate due to other reasons (4)
CL Item
Subject died (5)
DeathDate
Item
In case of death, please specify date
date
Date of Contact
Item
Date of Contact
date
Item Group
Investigator's Signature
Investigator name
Item
Investigator name
text
Signature:
Item
Signature:
text
Date:
Item
Date:
date

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial